company

NERSTAD BIOVARME AS

3350 PRESTFOSS

Return on Equity
−127,27 %
Current Ratio
1,48
Debt-to-Equity Ratio
410,82
Key figures (NOK)2022
Revenue54 000
Net Income−14 000
Total Assets6 421 000
Total Equity11 000
Income (NOK)2022
Revenue54 000
Expenditure55 000
Operating Profit−1 000
Financial Income0
Financial Costs19 000
Financial Balance−19 000
Earnings Before Tax−19 000
Tax−5 000
Net Income−14 000
Balance (NOK)2022
Total Fixed Assets3 622 000
Total Current Assets2 799 000
Total Assets6 421 000
Total Retained Equity−14 000
Total Equity11 000
Total Long-Term Debt4 519 000
Total Current Debt1 891 000
Total Equity and Debt6 421 000
Cash flow (NOK)2022
Sales Income54 000
Other Income0
Revenue54 000
Cost of Goods Sold54 000
Salary Costs0
Depreciation0
Impairment0
Expenditure55 000
Operating Profit−1 000
Financial Income0
Financial Costs19 000
Financial Balance−19 000
Dividends0
Net Income−14 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets5 000
Real Eastate3 616 000
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets3 616 000
Total Fiancial Fixed Assets0
Total Fixed Assets3 622 000
Stock0
Total Investments0
Cash, Bank1 847 000
Total Current Assets2 799 000
Total Assets6 421 000
Total Equity11 000
Short-Term Group Debt0
Total Long-Term Debt4 519 000
Creditors1 838 000
Unpaid Taxes0
Dividends0
Other Current Debt54 000
Total Current Debt1 891 000
Total Equity and Debt6 421 000
Financial indicators2022
Return on Equity−127,27 %
Debt-to-Equity Ratio410,82
Operating Profit Margin−1,85 %
Current Ratio1,48
Quick Ratio1,48
Equity Ratio0
Gross Profit Margin0 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English